Request Deal Involvement

GSK completed the acquisition of IDRx for $1.15bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Centerview Partners

financial advisors

Centerview Partners

Goodwin Procter

legal advisors

Goodwin Procter

Leerink Partners

financial advisors

Leerink Partners

Davis Polk & Wardwell

legal advisors

Davis Polk & Wardwell

Latham & Watkins

legal advisors

Latham & Watkins

Cooley

legal advisors

Cooley

or

Principals

IDRX

target

IDRX

GLAXOSMITHKLINE PLC

bidder

GLAXOSMITHKLINE PLC

B-FLEXION

vendor

B-FLEXION

RA CAPITAL MANAGEMENT

bidder

RA CAPITAL MANAGEMENT

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite